INTRODUCTION
The considerable worldwide investment in health research since the 1960s has resulted in remarkable advances in understanding disease processes, the molecular and genetic workings of biological systems, and increase in health and longevity in many countries. For example, the United States appropriations for biomedical research funding to the National Institute of Health (NIH) were $334.9 billion for the 55 year period ending in 2005(http:// officeofbudget.od.nih.gov/ui/AppropriationsHistoryByIC.htm). Such comprehensive figures for Europe or other international regions are difficult to find. The original European Union 15 countries (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden, UK) provided a funding of € 536.3 million (approximately $0.9 billion US) from 1993 -2003 . During the same period, NIH appropriations were $137.8 billion. Progress in improved health outcomes and increased longevity came from associating the responses of populations to nutrients (epidemiology), from inbred laboratory animal strains, and from in vitro systems. While gains in health measures have been impressive, it is still not possible to describe in full the interconnected metabolic and molecular pathways that lead to disease, or identify genetic susceptibility, let alone the combined use of the above for a mechanism based and "individualized" disease prevention and health optimization, which is, of course, the prime target for healthy nutrition.
Only recently has it become obvious that the standard research approaches, while producing data and in some cases useful and applicable knowledge, are at best, incomplete. One estimate is that most published research findings are statistically false (Ioannidis, 2005) COMMUNICA  COMMUNICA COMMUNICA  COMMUNICA COMMUNICATION, DA  TION, DA  TION, DA  TION, DA  TION, DAT T T  T TABASES, RESOUR  ABASES, RESOUR  ABASES, RESOUR  ABASES, RESOUR  ABASES, RESOURCES, AND  CES, AND  CES, AND  CES, AND  CES, AND TOOLS  TOOLS TOOLS  TOOLS sample sizes that lack appropriate statistical power, control groups that are not appropriately matched to cases, population stratification that occurs because of genetic admixtures among study participants, and over-interpretation of data (among others, see: [Cardon and Bell, 2001; Lander and Kruglyak, 1995; Risch, 1997; Tabor et al., 2002] ). HuGENet TM (http://www.cdc.gov/ genomics/hugenet/default.htm), a global collaboration of individuals and organizations committed to the analyses of human genome variation on population health and determination of how human genetic information can be used to improve health and prevent disease, was formed in 1998 in response to these concerns and to provide accurate information to scientists and the public (Khoury, 2004) . P 3 G, the Public Population Project in Genomics (http://www.p3gconsortium.org/), is another international network promoting transparency and collaboration for human epidemiology studies. More recently, members of the epidemiology community (Ioannidis et al., 2006) have announced a "network of investigator networks" for improving human genetic research for sharing best practices, tools, and methods for analyses of associations between genetic variation and common diseases (http://www.cdc.gov/genomics/hugenet/ default.htm).
We and others (Kaput, 2004; Kaput et al., 2005; Ordovas and Corella, 2004) added that (i) chronic disease may result from multiple molecular pathways that may obscure gene -disease or gene -nutrient -phenotype association analyses, (ii) the physiological response to the presence of a disease may alter expression of genetic information, (iii) genotype X environment interactions are rarely taken into account in nutritional or genetic epidemiological experiments, and these interactions are known to affect the expression of genetic information in response to different environments, (iv) ancestral background should be included because of epistasis (interaction of genes that are not alleles, especially the suppression of the effect of one gene by another), and (iv) laboratory animals and cultured cells may not account for genetic or nutritional variations found in humans.
The human genome (Lander et al., 2001; Venter et al., 2001 ) and HapMap (Consortium, 2004; Consortium, 2003; The International HapMap, 2005) projects have developed tools and produced genetic data that will be used to pursue the goals of personalized medicine and nutrition, but environmental variables (e.g. diet) must be included in experimental designs for epidemiology, laboratory animal, cell culture, and drug studies for this toolset to be of value. Recognizing and acknowledging the limitations of current research designs and strategies, 88 scientists from 22 countries called for strategic international alliances to harness nutrigenomic research for personal and public health (Kaput et al., 2005) . The goals outlined were to (i) create a federation for sharing data from cell culture experiments, laboratory animal studies, and in particular human nutritional intervention and cohort (prospective and retrospective) studies, (ii) develop more highly powered human studies, (iii) improve analyses and consistency of phenotypes, (iv) develop better measurements of food intake, (v) introduce controls for population stratification, (vi) analyze a wider array of genetic makeup by recruiting individuals from different ethnic groups, (vii) include other environmental variables that alter expression of genetic information, and (viii) promote interactions between academia and industry to convert knowledge for the public good.
Turning these lofty goals into reality is challenging even in the Internet age: we learn of studies and resources primarily through peer-reviewed publication, the end of the experiment and analyses processes rather than the beginning. To begin the process of converting these goals to practice, we are developing a nutrigenomics information portal that will serve the needs of academic scientists, consumers, health and allied professionals, and food, biotechnology, and pharmaceutical companies. We present these plans and progress to encourage others to contribute to their refinement and implementation. scientists, in order to improve the impact of nutrition in health promotion and disease prevention. NuGO has created a website environment that fosters communication among institutes, laboratories, and individuals. Many of the goals and plans for nurturing strategic collaborations within NuGO are similar to those of the International nutrigenomic community (see (Kaput et al., 2005) . NuGO has offered and already provides the resources and infrastructure to host the international nutrigenomics website, which will eliminate the need to find and justify funding from other countries and programs for the initial years of development of this knowledge structure. However, it is in the best interest of all that cost sharing is instituted in the future.
THE SITE MAP DRAFT THE SITE MAP DRAFT THE SITE MAP DRAFT THE SITE MAP DRAFT THE SITE MAP DRAFT As a part of the evaluation of requirements for a nutrigenomics information portal, we first focused on stakeholders who in one way or another have an interest in nutrigenomics. The four primary and broadly defined stakeholders are research and policy scientists, allied and professional health workers, the food, pharmaceutical, and biotechnology companies, and the consumer. Media interests are accommodated within all of these areas. Each of the four groups has slightly different interests and needs, all of which can be accommodated on one integrated website (Figure 1 ).
Research Scientists Research Scientists Research Scientists Research Scientists Research Scientists
A key stakeholder of the nutrigenomics information portal is the researcher. Our goal is to create an environment that will foster interactions, collaborations, and sharing of knowledge: research funding is scare and duplication of efforts is less than ideal. We describe key aspects of this virtual nutrigenomics society.
The need for registration Nutrition, and in some cases nutrigenomics, differs from many scientific disciplines because perceived "authority" often comes from publishing books for the general public, regardless of credentials or quality assurances for the information content. While there is a need for well-researched and written general audience texts, the discussions and collaborations we wish to foster require scientific expertise normally associated with advance degrees or publications in peer-reviewed journals. Access to the Nutrigenomics Research Portal section of the website will require registration. The established process (usually) requires one working day for the activation of privileges. In addition to individuals, we are asking that Centers, departments, companies, and other organizations register their expertise, resources, and interests, which will allow others to locate those interested in or working on specific nutrigenomic initiatives.
Several websites exist that describe networks or individual epidemiological projects (e.g., P 3 G). However, information about each project design requires (usually) extraction of the number of study participants, phenotypes, measured genotypes, or other study specific data elements by copy and paste into other software (such as worksheets). While larger projects develop websites, information about individual study specifics requires timeconsuming searches and copying, and publishing this information is a low priority. In contrast, the projects database envisioned for the Nutrigenomics Research Portal will be stored in a relational database allowing for data to be exported to other programs. For example, a researcher may want to know details of all planned or ongoing studies for Type 2 diabetes to identify one or more collaborators for increasing the power of experiments before publication. The international project registry database will not contain data from such studies but rather information about the studies' designs, sharing best practices whilst protecting research data before publication. Data from scientific studies will be deposited and managed in a separate set of databases also accessible from this site (Figure 2 , Global Biological Databases).
International Nutrient and Cultural Information
Nutrigenomic research requires knowledge of the nutrient composition of foods within a culture. Such databases have been developed for several countries but the macro-and micro-nutrient content of local foods remains a significant challenge for the diverse cultures and diets throughout the world. The Food and Agriculture Organization (FAO) of the United Nations (http:// www.fao.org/infoods/publications_en.stm) and various national governments have compiled food composition tables for many countries worldwide, but data must often be extracted from unlinked flat files or from publications and then it is incomplete particularly for bioactive compounds. A relational database of food composition is being developed by the European Food Information Resource Network (EuroFIR -http:// www.eurofir.net/) through international collaborations in partnership with national government agencies.
Nutrigenomicists are also beginning to account for cultural differences in food manufacturing, preparation, and eating which includes religious customs. Capturing this information in epidemiological studies will be another challenge for researchers. The type and detail that need or should be obtained for epidemiological studies will require discussions and consensus among nutrigenomics researchers.
A (Bioethics, 2005) . Their recommendations and policies will contribute to the design of human research studies throughout the world.
Best Practices
One of the most important aspects of the Nutrigenomics Society will be the development of best practices for improving the quality of experimental design, analyses, and results. NuGO already has begun this process with ongoing meetings and discussions among European scientists at different institutions. This effort has generated three best practices papers in transcriptomics (Garosi et al., 2005) , metabolomics , and proteomics (Fuchs et al., 2005) . These papers and recommendations focus on the technologies of each discipline rather than experimental designs for human, laboratory animal, cell culture experiments, or for pre-and post-experiment biocomputation methods. Because technologies and experience change, these best practices will require ongoing discussions, which will, in the near future, include non-European scientists. NuGO does not currently have teams dedicated solely to the development of food frequency questionnaires and physical activity measurement tools, and these may be initiated in collaborations among international and NuGO scientists in the near future. Online forums will be created to foster interactions across national and physical divides.
Discussion and exchange platform
The Nutrigenomics Information Portal allows for (and currently hosts) a large variety of nutrigenomics related discussions and forums, structured into a number of research, technology, training and "outreach" areas.
Global Biological Databases
The ultimate goal of the website, registration of individuals and projects, resource development, and best practice is to create data that can be shared across studies. The limitations imposed on nutrigenomic studies, specifically genetic variation, population architecture, individual and cultural food preferences, among others require large study populations and consistent phenotypes, common data elements, and database interoperability. None of these can be achieved without forethought and planning.
The databases described in Figure 2 , cohorts, transcriptomics, genetic variation, nutrient sensitive genes, metabolome, proteome, and biobanks will be developed in collaboration with ongoing efforts within NuGO and appropriate members of the international nutrigenomics community. These "omic" specific databases will be cross-linked to data from food frequency questionnaires or data generated by yet-to-be developed means for measuring food intakes accurately, a necessity for complete analyses of the datasets.
"High end" nutrigenomics applications
As nutrigenomics will need collaborations, standardization in data structures is essential. A number of tools are currently being developed and implemented related to a variety of applications. As an example, NuGO has adopted the Base2 LIMS system (http:/ /base.thep.lu.se/index.phtml) for coverage of data and study capture, and develops a nutrition and nutrigenomics specific ontology to link to Base in capturing the complete study. This will also serve for uploading datasets to public depositories like ArrayExpress (http://www.ebi.ac.uk/arrayexpress/). This activity aligns with the "Reporting Structure for Biological Investigations" (RSBI", http://www.mged.org/Workgroups/rsbi/rsbi.html) activity, which provides an overall structure for "omics" study capturing". Other high-end applications are related to data sharing and federation, allowing for cohort merging. P P P P Personaliz ersonaliz ersonaliz ersonaliz ersonalized N ed N ed N ed N ed Nutrition utrition utrition utrition utrition The consumer, designated here as Personalized Nutrition, is used as an example for describing the content of the site. We envision and plan to have 3 -5 experts contribute short (500 word) descriptions, in relation to nutrigenomics concepts and, where possible, data and results, on the topics listed to the left of this figure. These postings will likely be conservative descriptions of what is known and what has to be discovered on a specific concept with the goal of presenting or directing users to an authoritative source for information on a given topic. Certain topics in this section are modeled on the CENG website at UC Davis (http://nutrigenomics.ucdavis.edu > information > Concepts in Nutrigenomics). For consistency and accuracy, section editors will be recruited from the international community of researchers. These individuals will have responsibilities similar to those of any peer-reviewed journal. Converting the science for the lay public will likely require media and science writer expertise that will be recruited from academic centers or commercial enterprises specializing in these tasks. Overall editorial control will reside with a committee chosen by NuGO and the international scientists involved. The concept for this section will not be to dumb down the science, but rather to provide understandable balanced information. Each of these pages may be linked to organizations and agencies that provide other information relevant to the topic. For example, the cancer pages may be inked to the NCI web pages for patients, cardiovascular to NIH, the American Heart Association, the European Heart Network (http://www.ehnheart.org), similar educational groups or specific research projects worldwide.
Allied and Professional Health Allied and Professional Health Allied and Professional Health Allied and Professional Health Allied and Professional Health This stakeholder group consists of primary and specialty physicians, dietitians, genetic counselors, nurses, pharmacists, and others who interpret health information for the public and individual patients. These individuals are likely to request and require additional information about the details of studies, results, and opinions of experts about each of the topics shown in Figure  1 as it applies to their specialty. This information may be in the form of longer and more detailed description of individual or meta-analyses studies with links to primary documents and publications or clinical scenarios. Genetic counselors and dietitians versed in nutritional genomics concepts and technologies are likely authors for these topics in this section although some nutrigenomics scientists will also be involved.
Food, Pharmaceutical, and Biotechnology Food, Pharmaceutical, and Biotechnology Food, Pharmaceutical, and Biotechnology Food, Pharmaceutical, and Biotechnology Food, Pharmaceutical, and Biotechnology Improving personal and public health through nutrigenomics will not be possible unless knowledge is converted to products or technologies that are accessible to individuals in all countries. The Food, Pharmaceutical, and Biotechnology section of the nutrigenomics information portal will be written for professionals interested in translating basic research to marketable products. Market opportunities exist in virtually all of the topics listed in Figure 1 . The nature of competitive business practices and intellectual property considerations may require that this section be overviews of potential market possibilities as well as more basic information. Authors may be recruited from business schools or consortia of companies in the area. This section may serve as an information area for researchers and technology transfer agents at institutions to identify potential corporate partners giving an incentive for these commercial entities to participate.
A significant limitation for the involvement of commercial enterprises in developing nutrigenomics' products is that the majority of bioactives from food are generally regarded as safe (GRAS, a United States term) and as such, is not invented. That is, a company cannot patent an existing chemical and recover
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Y Y The proposed structure and topics of the nutrigenomics information portal and specifically the Nutrigenomic research web pages should be considered a work in progress. Our goal in publishing our activities and plans is precisely to solicit input in order to hone the utility of the website and planned databases. To participate, register at www.NuGO.org and request linkage to the international section. We view the development of these resources as an ongoing effort but also one that will be functional by the end of 2006. 
